Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Tekcapital plc (TEK.L)
London, GB
Tekcapital plc, an entity operating across the UK and US markets, specializes in providing technology commercialization services to both academic institutions and corporate entities. Its diverse product portfolio includes Microsalt, featuring finely milled, dissolvable, and Kosher-certified sodium chloride crystals, alongside low-sodium salted potato chips sold under the SaltMe! brand. Tekcapital also engages in the development and sale of stylish smart eyewear. Complementing this, it offers the Vyrb application, a voice-activated social media platform designed for Lucyd Lyte smart glasses and other hearable devices compatible with iOS and Android. Furthermore, the company creates and manages remote software solutions for monitoring and controlling, aimed at enhancing the safety of autonomous vehicles and ground-based delivery equipment. Established in 2014, Tekcapital plc maintains its principal office in London, United Kingdom.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -1.64% | -9.09% | -24.05% | -35.14% | -33.33% | -23.08% | -52.00% | -60.53% | -86.81% | -76.92% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Software - Application: +13.0%-33.0% Q4'25: +106.5% (vs Q4'23)
-
EPS growth Software - Application: +28.6%-202.6% Q4'25: -505.1% (vs Q4'23)
-
FCF margin FCF growth · Software - Application: +45.3%-652.5% Q4'25: -819.0% (vs Q4'23)
-
EBIT margin Software - Application: +9.4%-574.1% Q4'25: -711.8% (vs Q4'23)
-
ROIC Software - Application: +7.5%-3.0% Q4'25: -7.4% (vs Q4'23)
-
Share dilution Software - Application: +0.0%-11.5% ★ Q4'25: +33.6% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Software - Application: -1.16×0.00× Q4'25: 0.00× (vs Q4'23)
| Metric |
Dec 2014 actual |
|---|---|
| Revenue |
210.3K
est: 163.0K (+29.1%)
|
| EBITDA |
-908.0K
est: -40.3K (-2,150.3%)
|
| EBIT |
-913.6K
est: -40.4K (-2,162.4%)
|
| Net Income |
-994.9K
est: -11.38M (+91.3%)
|
| SGA |
1.12M
est: 90.0K (+1,149.3%)
|
| EPS |
-0.05
est: -0.06 (+14.3%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-28 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-27 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-26 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-22 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-21 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-20 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-19 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-18 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-15 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-14 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-13 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-12 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-11 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-08 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-07 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-06 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-05 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-01 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-30 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-29 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-28 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-27 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-24 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-23 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-22 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-21 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-20 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-17 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-16 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Clifford Mark Gross | Executive Chairman, Chief Executive Officer & Member of Science Advisory Board | 250.0K | — |
| Glen Gardner | President of Vortechs Group | — | male |
| Jay Shah | Chief Medical Officer of MicroSalt | — | — |
| Konrad Dabrowski | Chief Financial Officer | — | male |
| Michael S. Rosen | Managing Director of Academic & Entrepreneurship Training | — | male |
| Selwyn Lloyd | Chief Information Officer | — | male |
| Alexander Maxwell Hamilton Inglis | Co-Founder, General Counsel and Company Secretary | — | male |
| Victor Hugo Manzanilla | Chief Executive Officer of MicroSalt | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TEK.L
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
